VERTEX PHARMACEUTICALS INC (VRTX:NASDAQ)
$441.2 5.55 (1.274%)
Analysed VERTEX PHARMACEUTICALS INC (VRTX:NASDAQ) News Sources
Morgan Stanley Lifts Vertex Pharmaceuticals (VRTX) PT on Updated Biopharma Models
18-04-2026
yahoo.com
Vertex Pharmaceuticals (VRTX) Beats Stock Market Upswing: What Investors Need to Know
17-04-2026
yahoo.com
Vertex Pharmaceuticals (VRTX) Stock Slides as Market Rises: Facts to Know Before You Trade
16-04-2026
yahoo.com
Is Vertex Pharmaceuticals' Empire in Trouble?
16-04-2026
fool.com
1 S&P 500 Stock on Our Watchlist and 2 Facing Challenges
16-04-2026
yahoo.com
Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations
14-04-2026
yahoo.com
Vertex Pharmaceuticals price target raised to $612 from $596 at Morgan Stanley
11-04-2026
yahoo.com
Vertex Pharmaceuticals (VRTX) Dips More Than Broader Market: What You Should Know
10-04-2026
yahoo.com
Did Halozyme’s Vertex Hypercon Licensing Deal Just Shift Halozyme Therapeutics’ (HALO) Investment Narrative?
10-04-2026
yahoo.com
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
10-04-2026
yahoo.com
What is the current price of VERTEX PHARMACEUTICALS INC (VRTX:NASDAQ)?
The current price of VERTEX PHARMACEUTICALS INC (VRTX:NASDAQ) is $441.2.
VERTEX PHARMACEUTICALS INC (VRTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of VERTEX PHARMACEUTICALS INC (VRTX:NASDAQ) since the previous trading day is $5.55.
VERTEX PHARMACEUTICALS INC (VRTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of VERTEX PHARMACEUTICALS INC (VRTX:NASDAQ) since the previous trading day is 1.274%.
What is the most recent average sentiment score for VERTEX PHARMACEUTICALS INC (VRTX:NASDAQ)?
The most recent average sentiment score for VERTEX PHARMACEUTICALS INC (VRTX:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for VERTEX PHARMACEUTICALS INC (VRTX:NASDAQ)?
The most recent sentiment for VERTEX PHARMACEUTICALS INC (VRTX:NASDAQ) is .
SEC-8K** Filing Available For VERTEX PHARMACEUTICALS INC (VRTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.